{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:37:15Z","timestamp":1789432635369,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":55,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002062","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:33:39Z","timestamp":1069385619000},"source":"Crossref","is-referenced-by-count":24,"title":["Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy"],"prefix":"10.1002","author":[{"given":"Man Mohan","family":"Mehndiratta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,21]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD002062-BIB1|cit1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB2|cit2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archneur.62.2.249","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone","volume":"62","author":"Lopate","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD002062-BIB3|cit3","unstructured":"Van Schaik I Personal correspondence; PREDICT trial, a trial of intermittent dexamethasone versus continuous prednisolone 2008"},{"issue":"5","key":"10.1002\/14651858.CD002062-BIB4|cit4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002062-BIB5|cit5","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury","year":"1990","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB6|cit6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/brain\/81.2.157","article-title":"Recurrent polyneuropathies and their corticosteroid treatment. With five-year observations of a placebo controlled case treated with corticotrophin, cortisone and prednisone","volume":"81","author":"Austin","year":"1958","journal-title":"Brain"},{"issue":"4","key":"10.1002\/14651858.CD002062-BIB7|cit7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8","article-title":"Cyclosporin A in resistant chronic demyelinating polyradiculoneuropathy","volume":"21","author":"Barnett","year":"1998","journal-title":"Muscle & Nerve"},{"issue":"8","key":"10.1002\/14651858.CD002062-BIB8|cit8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002062-BIB9|cit9","first-page":"190","article-title":"Long term treatment of chronic inflammatory demyelinating polyradiculoneuropathy, combination of corticosteroids, plasma exchange and intravenous immunoglobulin","volume":"39","author":"Briellmann","year":"1998","journal-title":"European Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002062-BIB10|cit10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mus.20075","article-title":"Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data","volume":"30","author":"Bromberg","year":"2004","journal-title":"Muscle & Nerve"},{"issue":"22","key":"10.1002\/14651858.CD002062-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD002062-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2007.114868","article-title":"Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy","volume":"78","author":"Chi\u00f2","year":"2007","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD002062-BIB13|cit13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ana.410090719","article-title":"Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment","volume":"9","author":"Dalakas","year":"1981","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD002062-BIB14|cit14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jnnp.33.1.62","article-title":"Remarkable recovery of a steroid-responsive recurrent polyneuropathy","volume":"33","author":"DeVivo","year":"1970","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD002062-BIB15|cit15","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","article-title":"Pure motor demyelinating neuropathy: Deterioration after steroid treatment and improvement with intravenous immunoglobulin","volume":"57","author":"Donaghy","year":"1994","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD002062-BIB16|cit16","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD002062-BIB17|cit17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.410080608","article-title":"Human diabetic endoneurial sorbitol, fructose and myo-inositol related to sural nerve morphometry","volume":"6","author":"Dyck","year":"1980","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD002062-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.35.8.1173","article-title":"Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy","volume":"35","author":"Dyck","year":"1985","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002062-BIB19|cit19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002062-BIB20|cit20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1085-9489.2005.10302.x","article-title":"Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"10","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD002062-BIB21|cit21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp.2005.074781","article-title":"Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate","volume":"77","author":"Fialho","year":"2006","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD002062-BIB22|cit22","first-page":"1459","article-title":"Adrenocorticotropic hormones; adrenocortical steroids and their synthetic analogues, inhibitors of the synthesis and action of adrenocortical hormones","volume-title":"Goodman and Gilman. The Pharmacological basis of Therapeutics","author":"Bernard","year":"1996"},{"key":"10.1002\/14651858.CD002062-BIB23|cit23","first-page":"328","article-title":"Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies","volume":"152","author":"Hahn","year":"1996","journal-title":"Revue Neurologique (Paris)"},{"issue":"Pt 4","key":"10.1002\/14651858.CD002062-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. A double blind, sham-controlled, crossover study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1002\/14651858.CD002062-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","article-title":"Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD002062-BIB26|cit26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-510X(97)00216-5","article-title":"Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood","volume":"154","author":"Hattori","year":"1998","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD002062-BIB27|cit27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jnnp.53.4.327","article-title":"Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy","volume":"53","author":"Hodgkinson","year":"1990","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB28|cit28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD002062-BIB29|cit29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003280.pub2","article-title":"Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Hughes","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002062-BIB30|cit30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","article-title":"Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"11","author":"Hughes","year":"2006","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD002062-BIB31|cit31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ana.410400626","article-title":"Biopsy findings link multifocal motor neuropathy to chronic inflammatory demyelinating polyneuropathy","volume":"40","author":"Krendel","year":"1996","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD002062-BIB32|cit32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD002062-BIB33|cit33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in Southeast England","volume":"66","author":"Lunn","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB34|cit34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jnnp.60.2.185","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A","volume":"60","author":"Mahattanakul","year":"1996","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"Pt 6","key":"10.1002\/14651858.CD002062-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"issue":"3","key":"10.1002\/14651858.CD002062-BIB36|cit36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003906.pub2","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002062-BIB37|cit37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.62.4.388","article-title":"Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: A pilot study","volume":"62","author":"Molenaar","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002062-BIB38|cit38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1212\/WNL.47.1.98","article-title":"Childhood chronic inflammatory demyelinating neuropathies","volume":"47","author":"Nevo","year":"1996","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD002062-BIB39|cit39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archneur.1978.00500320029007","article-title":"Subacute demyelinating polyneuropathy responding to corticosteroid treatment","volume":"35","author":"Oh","year":"1978","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB40|cit40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.880110203","article-title":"Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease","volume":"11","author":"Parry","year":"1988","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD002062-BIB41|cit41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"10.1002\/14651858.CD002062-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1569::AID-MUS12>3.0.CO;2-W","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in children. II. Long term follow-up, with comparison to adults","volume":"20","author":"Simmons","year":"1997","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD002062-BIB43|cit43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.410200113","article-title":"Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid responsive disorder","volume":"20","author":"Sladky","year":"1986","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002062-BIB44|cit44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/92.3.589","article-title":"Recurrent and chronic relapsing Guillain-Barre polyneuritis","volume":"92","author":"Thomas","year":"1969","journal-title":"Brain"},{"issue":"3","key":"10.1002\/14651858.CD002062-BIB45|cit45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003217.pub2","article-title":"Immunosuppressive agents for multifocal motor neuropathy","author":"Umapathi","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002062-BIB46|cit46","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/ana.410370704","article-title":"Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies","volume":"37","author":"Mech\u00e9","year":"1995","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB47|cit47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1991.00530140113024","article-title":"High-dose intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy","volume":"48","author":"Doorn","year":"1991","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB48|cit48","first-page":"220","article-title":"Treatment of Guillain-Barr\u00e9 syndrome and CIDP","volume":"10","author":"Doorn","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB49|cit49","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Schaik","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD002062-BIB50|cit50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD002062-BIB51|cit51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.56.1.36","article-title":"Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study","volume":"56","author":"Vermeulen","year":"1993","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002062-BIB52|cit52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1445-5994.1979.tb04326.x","article-title":"Progressive polyradiculoneuropathy: treatment with azathioprine","volume":"9","author":"Walker","year":"1979","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD002062-BIB53|cit53","unstructured":"World Health Organisation International Classification of Impairment Bulletin of the World Health Organisation 1980"},{"key":"10.1002\/14651858.CD002062-BIB54|cit54","unstructured":"World Health Organisation ICIDH-2: International classification of Impairments, Activities, and Participation Bulletin of the World Health Organisation 1997"},{"issue":"7678","key":"10.1002\/14651858.CD002062-BIB55|cit55","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(70)92019-2","article-title":"Treatment of polyneuropathy with azathioprine","volume":"2","author":"Yuill","year":"1970","journal-title":"Lancet"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002062\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:08:53Z","timestamp":1628543333000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002062"}},"subtitle":[],"editor":[{"given":"Man Mohan","family":"Mehndiratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2002,1,21]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002062","relation":{},"subject":[],"published":{"date-parts":[[2002,1,21]]}}}